Waterlooville man who lost his wife to bowel cancer welcomes research breakthrough
A Waterlooville father who lost his wife to bowel cancer after living with colitis for more than half her life, has welcomed ...
Palisade Bio Selected for Poster Presentation at the 2025 Crohn’s & Colitis Congress
Session: Poster and Exhibition Hall Reception Poster Title:PALI-2108, a Colon-Specific PDE4B Inhibitor Prodrug is Activated in the Colon and Reduces Ulcerative Colitis Symptoms in an Acute Colitis DSS ...
Teva's Duvakitug Set To Shake Up IBD Treatment, Analyst Highlights Competitive Data
Piper Sandler analyst maintains an Overweight rating on Teva, citing positive feedback on duvakitug's potential in treating ...
Inflammatory Bowel Disease Market Set For Strong Growth By 2034, Predicts Delveinsight
DelveInsight's Inflammatory Bowel disease market Report provides comprehensive insights into the epidemiology and market dynamics across the 7MM. LAS VEGAS , NV, UNITED STATES, January 30, 2025 ...
Jewish Press23h
Targeted mRNA Therapy Holds Promise for Crohn’s Disease, Colitis, and Beyond
The findings suggest that lipid composition can direct mRNA-based drugs to target organs, such as the intestines, without passing through the liver.
NewsX10h
New Groundbreaking Test Might Predict Bowel Cancer Risk With Up To 90% Accuracy
Scientists have developed a groundbreaking test that may predict bowel cancer risk with up to 90% accuracy. The research, ...
Groundbreaking new test 90% accurate in finding patients at high risk of bowel cancer
Doctors believe new test could lead to earlier diagnoses and more effective treatment for thousands of patients ...
Medical News Today6d
Behind the Counter: What to know about second-line treatments for ulcerative colitis
Ulcerative colitis (UC) symptoms may include abdominal pain, cramping, and diarrhea. People can experience periods of remission followed by flare-ups, which can lead to treatment changes.
Ibj.com23h
Lilly’s Omvoh part of company’s expansion into inflammatory bowel disease treatment
The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...
The Korea Bizwire8h
South Korean Pharmaceutical Companies Make Bold Push Into Autoimmune Disease Market
Celltrion, a leading Korean biotechnology firm, has successfully developed Zymfentra, a subcutaneous version of the company’s ...
The American Journal of Managed Care5d
FDA Approves Mirikizumab for Crohn Disease
The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...
Researchers successfully deliver mRNA-based drugs to the intestine – without passing through the liver
Researchers at Tel Aviv University have achieved a major breakthrough in drug delivery: they have successfully transported lipid nanoparticles encapsulating messenger RNA (mRNA) to the immune system ...